Relatório global de análise do tamanho, quota e tendências do mercado de canábis médica – Visão geral do setor e previsão para 2031

Análise do mercado de canábis medicinal

O mercado da canábis medicinal tem registado um crescimento significativo nos últimos anos, impulsionado pelo crescente reconhecimento dos seus benefícios terapêuticos para diversas condições médicas. Com os esforços de legalização a ganharem força em múltiplas regiões, a procura de produtos de canábis medicinal está a aumentar. Este mercado abrange uma vasta gama de produtos, incluindo óleos, cápsulas e comestíveis, adaptados para condições como a dor crónica , epilepsia e perturbações de saúde mental. Os desenvolvimentos recentes, como os avanços nas técnicas de cultivo e nos processos de extração, melhoraram a qualidade e a eficácia dos produtos, alimentando ainda mais a expansão do mercado. Além disso, a crescente sensibilização e aceitação dos consumidores, juntamente com as políticas governamentais de apoio, são factores-chave que contribuem para as perspectivas positivas do mercado. À medida que a investigação continua a revelar os potenciais benefícios da canábis, o mercado da canábis medicinal está preparado para um crescimento sustentado, oferecendo novas oportunidades tanto para as empresas farmacêuticas como para os prestadores de cuidados de saúde.

Tamanho do mercado de canábis medicinal

O tamanho do mercado global de canábis medicinal foi avaliado em 21,06 mil milhões de dólares em 2023 e deverá atingir os 108,90 mil milhões de dólares até 2031, com um CAGR de 22,80% durante o período de previsão de 2024 a 2031. Além dos insights sobre os cenários de mercado, como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também a análise especializada aprofundada, a epidemiologia dos doentes, a análise de pipeline, a análise de preços e a estrutura regulatória.

Tendências do mercado da canábis medicinal

“ Procura por produtos de canábis personalizados”

O mercado da canábis medicinal está a assistir a tendências transformadoras impulsionadas pela inovação e pela evolução das preferências dos consumidores. Uma tendência notável é a crescente procura de produtos de canábis personalizados, onde os consumidores procuram formulações personalizadas para abordar condições de saúde específicas e necessidades individuais. As inovações nas técnicas de extração e formulação de canábis estão a permitir o desenvolvimento de diversas ofertas de produtos, como óleos específicos e alimentos infundidos, que melhoram os efeitos terapêuticos. Além disso, os avanços na tecnologia, incluindo a utilização de inteligência artificial e análise de dados no cultivo e na gestão da cadeia de abastecimento, estão a optimizar os processos de produção e a garantir a consistência dos produtos. No geral, estas tendências refletem uma mudança para soluções de canábis medicinal mais eficazes e personalizadas, atendendo às diversas necessidades dos pacientes e impulsionando o crescimento do mercado.

Âmbito do relatório e segmentação do mercado de canábis medicinal  

Definição de mercado de canábis medicinal

A canábis medicinal refere-se à utilização da planta canábis e seus derivados para fins terapêuticos . Abrange uma variedade de produtos, incluindo óleos, cápsulas, tinturas e formulações tópicas, contendo canabinóides como o tetrahidrocanabinol (THC) e o canabidiol (CBD). A canábis medicinal é prescrita para aliviar os sintomas associados a vários problemas de saúde, incluindo dor crónica, epilepsia, esclerose múltipla, náuseas causadas pela quimioterapia e ansiedade. A sua utilização é frequentemente regulada por leis que variam de acordo com a região e é normalmente recomendada quando os tratamentos convencionais se revelam ineficazes.

Dinâmica do mercado da canábis medicinal

Motoristas

• Aumentando a aceitação e legalização

A crescente aceitação da canábis medicinal entre os profissionais de saúde e os doentes com canábis medicinal é um motor significativo do crescimento do mercado. À medida que a investigação continua a revelar os benefícios terapêuticos dos canabinóides para várias condições médicas, os prestadores de cuidados de saúde estão mais inclinados a recomendar a canábis como opção de tratamento. Esta mudança na perceção levou a uma maior consciencialização e vontade dos pacientes em considerar a canábis medicinal para gerir a dor crónica, a ansiedade e outras doenças. Além disso, a legalização da canábis medicinal em numerosas regiões facilitou ainda mais a sua integração nos cuidados de saúde convencionais. Esta alteração regulamentar legitima a sua utilização e incentiva o investimento em investigação e desenvolvimento de produtos, alargando assim o mercado. Espera-se que o efeito combinado destes fatores promova um crescimento significativo no mercado da canábis medicinal.

•  Aumento da prevalência de doenças crónicas

The rising incidence of chronic diseases, including cancer, epilepsy, and multiple sclerosis, has created a substantial demand for effective pain management and therapeutic solutions, significantly boosting the medical cannabis market. Patients suffering from these conditions often experience severe pain, discomfort, and a range of debilitating symptoms that conventional treatments may not adequately address. Medical cannabis, with its diverse array of cannabinoids, offers a natural alternative that can alleviate pain and improve quality of life. As healthcare providers increasingly recognize the potential of cannabis-based treatments, more patients are being referred to medical cannabis as a viable option. This growing acceptance, alongside ongoing research demonstrating the efficacy of cannabis for symptom relief, continues to propel market growth as patients seek effective and holistic approaches to managing their health conditions.

Opportunities

• Integration with Traditional Healthcare

Collaborations between cannabis companies and traditional healthcare providers present a significant opportunity for market growth in the medical cannabis sector. By partnering with healthcare professionals, cannabis companies can enhance the legitimacy of their products and foster trust among potential patients. These collaborations can lead to the development of educational programs and clinical guidelines, making healthcare providers more comfortable recommending cannabis therapies as part of a comprehensive treatment plan. As healthcare providers gain confidence in the efficacy and safety of medical cannabis, they are more likely to advocate for its use, ultimately increasing patient access to these therapies. This integration broadens the market reach of cannabis products and contributes to the overall acceptance of medical cannabis within mainstream healthcare, driving sustained market expansion.

• Advancements in Research and Development

Ongoing research into the therapeutic benefits of cannabinoids is unlocking new opportunities in the medical cannabis market. As scientists and healthcare professionals continue to explore the medicinal properties of various cannabinoids, they are discovering innovative applications for conditions ranging from chronic pain and anxiety to neurological disorders. This research has led to the development of new medical cannabis products, expanding the variety of treatment options available to patients. Such advancements cater to diverse patient needs and enhance the efficacy and safety profiles of cannabis-based therapies. As more clinical studies validate the benefits of these products, they are likely to gain acceptance among healthcare providers and patients alike. This expansion of product offerings presents a lucrative opportunity for companies to capture a larger share of the growing medical cannabis market, ultimately improving patient outcomes and satisfaction.

Restraints/Challenges

• Lack of Standardized Regulations

The medical cannabis market faces significant challenges due to the lack of standardized regulations and the varying legal frameworks across different regions. Each jurisdiction has its own rules governing the cultivation, distribution, and sale of medical cannabis, creating a complex landscape for companies to navigate. This regulatory inconsistency often results in confusion and delays in market entry for new players. Companies may spend considerable time and resources understanding local laws, obtaining necessary licenses, and ensuring compliance with diverse regulations. These hurdles can deter potential investors and limit the growth of the market. Consequently, the absence of a unified regulatory approach poses a significant challenge to the expansion and accessibility of medical cannabis products globally.

•  Competition from Traditional Therapies

Established pharmaceutical treatments continue to hold a significant share of the healthcare market, often backed by extensive research, clinical trials, and regulatory approvals. These conventional therapies are widely prescribed by healthcare professionals and have a long-standing reputation for safety and efficacy. As a result, patients and doctors may be hesitant to consider medical cannabis products as viable alternatives, especially in serious conditions like cancer and chronic pain. The familiarity and trust in traditional medications can hinder the adoption of medical cannabis, despite its potential benefits. This reliance on established treatments limits the market growth for cannabis-based therapies, as healthcare professionals may prioritize familiar pharmaceutical options over newer, less understood cannabis products. This restraint creates a challenge for the medical cannabis market to gain traction among patients and healthcare providers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Medical Cannabis Market Scope

The market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Oil
• Medical Cannabis Capsules
• Patch
• Whole Flower
• Ground Flower
• Vape Pen
• Dried Medical Cannabis
• Creams & Moisturizers
• Masks & Serum
• Cleanser
• Others

Source

• Natural
• Synthetic

Species

• Cannabis Indica
• Cannabis Sativa
• Hybrid

Application

• Alzheimer’s Disease
• Appetite Loss
• Cancer
• Inflammatory Bowel Diseases
• Eating Disorders
• Epilepsy
• Autism
• Mental Health Conditions
• Multiple Sclerosis
• Pain Management
• Nausea
• Muscle Spasms
• Wasting Syndrome (Cachexia)
• Elevate Mood
• Depression and Sleep Disorders
• Anxiety
• Others

Derivatives

• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC) / Delta-8-Tetrahydrocannabinol
• Cannabinol (CBN)
• Cannabicyclol (CBL)
• Cannabichromene (CBC)
• Cannabigerol (CBG)
• Others

Treatment Type

• Expectorant
• Antiviral
• Analgesic
• Aphrodisiac
• Psychedelic
• Others

Route of Administration

• Oral Solutions and Capsules
• Smoking
• Vaporizers
• Topicals
• Others

End User

• Pharmaceutical Industry
• Research and Development Centers
• Homecare Setting
• Hospitals
• Rehab Centers
• Others

Distribution Channel

• B2B
• B2C

 Medical Cannabis Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global medical cannabis market due to the increasing investment in medical cannabis. The U.S. is expected to dominate the North America region due to the legalization of medical cannabis use. Germany is expected to dominate the Europe region due to the increasing demand for medical cannabis in emerging markets and expansion. Australia is expected to dominate the Asia-Pacific region due to the presence of key manufacturers and advanced technological processes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Medical Cannabis Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Medical Cannabis Market Leaders Operating in the Market Are:

• MediPharm Labs Inc. (Canada)
• Tilray (Canada)
• Aurora Cannabis (Canada)
• JAZZ Pharmaceuticals Inc. (U.K.) (GW Pharmaceuticals plc)
• HEXO Corp. (Canada) (Zenabis Global Ltd)
• Cresco Labs (U.S.)
• Peace Naturals Project Inc. (Canada)
• CANOPY GROWTH CORPORATION (Canada)
• Medical Marijuana, Inc. (U.S.)
• Seed Cellar (U.S.)
• EcoGen Biosciences (U.S.)
• CANNABIS SEEDS USA (U.S.)
• Seeds For Me (U.S.)
• HUMBOLDT SEED COMPANY (U.S.)
• Extractas (U.S.)
• World Class Cannabis Seeds (Crop King Seeds) (Canada)
• BARNEY'S FARM (Netherlands)
• FOLIUM BIOSCIENCES (U.S.)
• PharmaHemp (U.K.)
• Elixinol Global Limited (Australia)
• ENDOCA (Netherlands)
• Harmony (U.K.)
• MARY’S Nutritionals, LLC (U.S.)
• Pure Ratios (U.S.)
• Greenwich Biosciences, Inc. (U.S.)
• Upstate Elevator Supply Co. (U.S.)
• Apothecanna (U.S.)
• BOL Pharma (Israel)
• IDT Australia (Australia)

Latest Developments in Medical Cannabis Market

• In February 2023, Aurora Cannabis Inc., a Canadian company specializing in global cannabis distribution, collaborated with MedReleaf Australia to launch CraftPlant, a new medical cannabis brand for the Australian market. The initial offerings from CraftPlant include three products—Greendae, Navana, and HiVolt—all of which are now available for prescription by doctors. Each strain boasts a high THC concentration and is sourced from premium cultivars developed by Occo, Aurora's leading scientific and genetics company, and will be packaged in 10g canisters produced under strict EU-GMP authorized standards
• In July 2023, Carer, an oncology company in India, announced a partnership with Wholeleaf, a certified manufacturer of medicinal cannabis and cannabidiol. This collaboration aims to improve the overall well-being of cancer patients by offering comprehensive support that includes nutrition for caregivers, physical therapy, and mental health services. With official approval from the Ayush ministry to manufacture and market its products nationwide, CARER and Wholeleaf are combining their services to deliver a holistic solution for cancer care
• Em setembro de 2023, a Alternaleaf, uma clínica reconhecida por ajudar os australianos a obter canábis medicinal, anunciou a sua expansão para o Reino Unido. A investigação indica que a Inglaterra está no bom caminho para se tornar o segundo maior mercado de canábis medicinal na Europa, impulsionada pela procura crescente. Com mais de 360.000 casos notificados de dependência de opiáceos no Reino Unido, os especialistas sugerem que a canábis medicinal pode servir como uma alternativa viável aos opiáceos, que são frequentemente prescritos desnecessariamente.
• Em abril de 2022, a Medi Cane Health Inc. e a Dr. Reddy's Laboratories Ltd. lançaram o seu produto de canábis medicinal na Alemanha. Esta colaboração visa satisfazer a crescente procura por soluções de canábis medicinal na região. A introdução deste produto marca um passo significativo na expansão do acesso a opções terapêuticas de canábis para doentes na Alemanha
• Em abril de 2022, a cidade de Nova Iorque testemunhou as suas primeiras vendas legais de marijuana, ocorridas apenas um mês depois de sete empresas de marijuana medicinal terem recebido aprovação para vender os seus produtos a todos os adultos. Este marco significa uma mudança significativa no panorama da canábis no estado, alargando o acesso para além do uso medicinal. A iniciativa visa criar um mercado regulamentado, beneficiando ao mesmo tempo as economias locais e garantindo a segurança do consumidor

SKU-52961